Ventyx Biosciences, Inc.
VTYXNASDAQHealthcare
$14.00
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio—
52W High$25
52W Low$0.783
Ventyx Biosciences, Inc. (VTYX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · VTYX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.12B | $0.18B | $0.09B | $0.06B | $0.01B |
| G&A Expenses | $0.03B | $0.03B | $0.03B | $0.01B | $0.00B |
| Total Operating Expenses | $0.15B | $0.21B | $0.11B | $0.07B | $0.01B |
| Operating Income | ($0.15B) | ($0.21B) | ($0.11B) | ($0.07B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01B | $0.02B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.14B) | ($0.19B) | ($0.11B) | ($0.08B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.14B) | ($0.19B) | ($0.11B) | ($0.08B) | ($0.03B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.97 | $-3.30 | $-2.06 | $-1.69 | $-0.56 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.15B) | ($0.21B) | ($0.11B) | ($0.08B) | $0.00B |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Ventyx Biosciences, Inc. data
About Ventyx Biosciences, Inc. (VTYX) Income Statement
Ventyx Biosciences, Inc. (VTYX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, VTYX reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.14B) — a net profit margin of —.
Frequently asked questions
VTYX · 4 questionsVentyx Biosciences, Inc. (VTYX) reported revenue of $0.00B for 2024, down —% year-over-year.
VTYX revenueVTYX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08